Ultragenyx Pharmaceutical, Inc. (RARE)
23.75
+0.04
(+0.17%)
USD |
NASDAQ |
May 22, 09:47
Ultragenyx Pharmaceutical Total Assets (Quarterly) : 1.296B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| BioMarin Pharmaceutical, Inc. | 8.591B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Xencor, Inc. | 736.85M |
| REGENXBIO, Inc. | 341.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.525B |
| Shareholders Equity (Quarterly) | -236.00M |
| Debt to Equity Ratio | -5.085 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -2.82% |